Your browser doesn't support javascript.
loading
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Boucher, Justin C; Shrestha, Bishwas; Vishwasrao, Paresh; Leick, Mark; Cervantes, Estelle V; Ghafoor, Tayyebb; Reid, Kayla; Spitler, Kristen; Yu, Bin; Betts, Brian C; Guevara-Patino, Jose A; Maus, Marcela V; Davila, Marco L.
Afiliación
  • Boucher JC; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Division of Clinical Science, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Shrestha B; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Vishwasrao P; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Division of Clinical Science, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Leick M; Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA 91010, USA.
  • Cervantes EV; Department of Hematology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Ghafoor T; Cellular Immunotherapy Program. Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
  • Reid K; University of South Florida, Tampa, FL 33612, USA.
  • Spitler K; University of South Florida, Tampa, FL 33612, USA.
  • Yu B; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Division of Clinical Science, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Betts BC; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Division of Clinical Science, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Guevara-Patino JA; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Division of Clinical Science, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
  • Maus MV; Division of Hematology, Oncology, and Transplant, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Davila ML; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Mol Ther Oncolytics ; 31: 100751, 2023 Dec 19.
Article en En | MEDLINE | ID: mdl-38075241
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos